1st Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

The 21st Century Cures Act Orphan Drug Tax Credit Advancing Hope Act of 2015 Ensuring Access to Clinical Trials Act Patients' Access to Treatments Act Trade Promotion Authority Childrens Access to Specialty Care Act of 2015

LobbyistCovered position, as disclosed
DIANE EDQUIST DORMAN VP Public Policy
PAUL MELMEYER Associate Director of Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Social Security Administration (SSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.